2020 TTF ALK SESSION QA PANEL The Use of an ALK TKI Post Chemoradiation for Stage 3B Lung Cancer

dbrock's picture

Submitted by dbrock on Fri, 06/18/2021 - 17:27

2020 TTF ALK SESSION Question and Answer Session with Drs Raez and Lin - The Use of an ALK TKI Post Chemoradiation for Stage 3B Lung Cancer
Luis Raez, MD FACP FCCP, Faculty, Board Member
PDF icon Download Transcript Here
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time!

But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available!

This past event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer.

In this video from the ALK and ROS1 panel discussion from the event, Dr. Jessica Lin and Dr. Luis Raez discuss the use of an ALK TKI post chemoradiation for stage 3B lung cancer.

 

We thank our sponsors for their support of this event! #AstraZeneca #Lilly #Novartis #Takeda #FoundationMedicine #BoehringerIngelheim #BlueprintMedicines #Genentech

 

To join the conversation, visit https://cancergrace.org/forum.

 

 

Related Content: 
2020 TTF ALK SESSION RAEZ Sequence of ALK Inhibitors
2020 TTF ALK SESSION - LIN - TKIs for ROS1
Video Language: 
English

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation